Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease

ClinicoEconomics and Outcomes Research

Volumn 7, Issue , 2015, Pages 37-51

  Yu, Tzy Chyi ^a   Zhou, Huanxue ^b   Suh, Kangho ^a   Arcona, Stephen ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b KMK Consulting Inc   (United States)

Author keywords

Administrative claims; COPD; Dominance analysis; Predictor importance; Unplanned readmission

Indexed keywords

BRONCHODILATING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE;

ADULT; AGE; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSPNEA; FEMALE; GENDER; HEART FAILURE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OXYGEN THERAPY; PATIENT COMPLIANCE; PNEUMONIA; PREDICTION; PULMONARY VASCULAR DISEASE; RETROSPECTIVE STUDY; WINTER;

EID: 84920988887     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S74181     Document Type: Article

References (44)

1. Minott J. Reducing hospital readmissions. AcademyHealth website; 2008. Available from: http://www.academyhealth.org/files/publications/Reducing_Hospital_Readmissions.pdf. Accessed July 29, 2014.
2. Rau J. Medicare to penalize 2,217 hospitals for excess readmissions. Kaiser health news website; 2012. Available from: http://www.kaiserhealthnews.org/stories/2012/august/13/medicare-hospitals-readmissions-penalties.aspx. Accessed July 29, 2014.
3. Aetna, Genesis HealthCare Take Aim At Preventing Hospital Readmissions. Aetna Website; 2011. Available from: https://www1.aetna.com/news/newsReleases/2011/0810_Aetna-Genesis_Hospital-Readmissions.html. Accessed August 15, 2014.
4. Carroll J. It’s in insurers’ interest to help cut readmissions. Manag Care. 2012;21(10):5–6.
5. Adamy J. WellPoint shakes up hospital payments. Wall Street Journal website; 2011. Available from: http://online.wsj.com/news/articles/SB10001424052748704281504576325163218629124. Accessed July 29, 2014.
6. Cigna Teams With CareCentrix to Reduce Hospital Readmissions. Cigna Website; 2010. Available from: http://newsroom.cigna.com/article_display.cfm?article_id=1222. Accessed August 15, 2014.
7. Hines AL, Barrett ML, Jiang HJ, Steiner CA. Conditions with the largest number of adult hospital readmissions by payer, 2011. HCUP Statistical Brief #172. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb172-Conditions-Readmissions-Payer.pdf. Accessed August 15, 2014.
8. Readmission reduction program. Centers for Medicare and Medicaid Services website; 2014. Available from: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html. Accessed July 29, 2014.
9. Medicare Payment Advisory Commission. Report to Congress: reforming the delivery system. Washington, DC; 2008. Available from: http://www.medpac.gov/documents/reports/Jun08_EntireReport.pdf?sfvrsn=0. Accessed July 29, 2014.
10. US National Institutes of Health, National Heart Lung and Blood Institute. Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD; 2012. Available from: http://www.nhlbi.nih.gov/fles/docs/research/2012_ChartBook.pdf. Accessed August 15, 2014.
11. Elixhauser A, Au DH, Podulka J. Readmissions for chronic obstructive pulmonary disease, 2008. HCUP Statistical Brief #121. Rockville, MD: Agency for Healthcare Research and Quality; 2011. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb121.pdf. Accessed July 29, 2014.
12. Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011. Statistical Brief #160. Rockville, MD: Agency for Healthcare Research and Quality; 2013. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb160.jsp. Accessed July 29, 2014.
13. Amarasingham R, Moore BJ, Tabak Y P, et al. An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Med Care. 2010;48(11):981–988.
14. Keenan PS, Normand SL, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1(1):29–37.
15. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2(5): 407–413.
16. Garcia-Aymerich J, Farrero E, Félez MA, et al; Estudi del Factors de Risc d’Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–105.
17. Garcia-Aymerich J, Hernandez C, Alonso A, et al. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med. 2007;101(7):1462–1469.
18. Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic review. Respir Res. 2005;6:54.
19. Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551–559.
20. Truven Health Analytics. 2012. Available from: http://truvenhealth.com/your-healthcare-focus/analytic-research/marketscan-research-databases. Accessed July 23, 2014.
21. Grosso LM, Lindenauer P, Wang C, et al. Hospital-level 30-day readmission following admission for an acute exacerbation of chronic obstructive pulmonary disease. Centers for Medicare and Medicaid Services website. 2011. Available from: http://www.cms.gov/Medicare/ Quality-Initiatives-Patient-Assessment-Instruments/Hospital QualityInits/Measure-Methodology.html. Accessed July 29, 2014.
22. Barba R, de Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor. Curr Med Res Opin. 2012;28(4):617–622.
23. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128(4):2005–2011.
24. Nantsupawat T, Limsuwat C, Nugent K. Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chron Respir Dis. 2012;9(2):93–98.
25. Ng T P, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–67.
26. Xu W, Collet J P, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913–920.
27. Shams I, Ajorlou S, Yang K. A predictive analytics approach to reducing 30-day avoidable readmissions among patients with heart failure, acute myocardial infarction, pneumonia, or COPD. Health Care Manag Sci. Epub 2014 May 3.
28. Sharif R, Parekh TM, Pierson KS, Kuo Y-F, Sharma G. Predictors of early readmission among patients aged 40 to 64 years hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5): 685–694.
29. Wu EQ, Birnbaum HG, Cifaldi M, Kang Y, Mallet D, Colice G. Development of a COPD severity score. Curr Med Res Opin. 2006; 22(9):1679–1687.
30. Laratta CR, van Eeden S. Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links. Biomed Res Int. 2014;2014:18.
31. Nau D P. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. 2012. Available from: http://ep.yimg.com/ty/cdn/epill/pdcmpr.pdf. Accessed August 15, 2014.
32. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4): 361–387.
33. Azen R, Traxel N. Using dominance analysis to determine predic­tor importance in logistic regression. J Educ Behav Stat. 2009;34: 319–347.
34. Johnson JW, Lebreton JM. History and use of relative importance indices in organizational research. Organ Res Meth. 2004;7:238–257.
35. Johnson JW. A heuristic method for estimating the relative weight of predictor variables in multiple regression. Multivariate Behav Res. 2000;35(1):1–19.
36. Grömping U. Estimators of relative importance in linear regression based on variance decomposition. Am Stat. 2007;61(2):139–147.
37. Budescu DV. Dominance analysis: a new approach to the problem of relative importance of predictors in multiple regression. Pyschol Bull. 1993;114:542–551.
38. Budescu DV, Azen R. Beyond global measures of relative importance: some insights from dominance analysis. Organ Res Meth. 2004;7: 341–350.
39. Lebreton JM, Binning JF, Adorno AJ, Melcher KM. Importance of personality and job-specific affect for predicting job attitudes and withdrawal behavior. Organ Res Meth. 2004;7(3):300–325.
40. Paul P, Pennell ML, Lemeshow S. Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets. Stat Med. 2013;32(1):67–80.
41. Steyerberg EW, Vickers AJ, Cook NR, etal. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128–138.
42. Mapel DW, Robinson SB, Dastani HB, Shah H, Phillips AL, Lydick E. The direct medical costs of undiagnosed chronic obstructive pulmonary disease. Value Health. 2008;11(4):628–636.
43. Tonidandel S, Lebreton JM. Relative importance analysis: a useful supplement to regression analysis. J Bus Psychol. 2011;26:1–9.
44. Luchman JN. DOMIN: Stata module to conduct dominance analysis. 2013. Available from: http://fmwww.bc.edu/repec/bocode/d/domin.sthlp. Accessed August 29, 2014.